Science Explorer Interactive view Map
Company · Rome · Italy

Nouscom (Italy)

Research works
21
▲ 303% vs 2013–17
Citations
411
19.5 per fractional work
Top-10% rate
23.2%
record average 16.5%
Open access
82%
world 28%

Not ranked overall: Nouscom (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Nouscom (Italy)?

Ranked on the composite score, Elisa Scarselli lead among researchers whose main affiliation is Nouscom (Italy).

  1. 1 Elisa Scarselli Italy · #1,429,184 worldwide 13 citations · 19 works
All ranked researchers at Nouscom (Italy)

Which keywords describe research at Nouscom (Italy)?

By fractional works in all years, weighted toward what it does more of than the world: Antigen Presentation, Cancer Immunotherapy, Gene Therapy, Innate Immunity, Immunity, AAV, Viral Vectors and Dendritic Cells.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Antigen Presentation4▲ 198×2 topics
  2. Cancer Immunotherapy4▲ 126×2 topics
  3. Gene Therapy3▲ 61×2 topics
  4. Innate Immunity3▲ 44×2 topics
  5. Immunity3▲ 43×2 topics
  6. AAV3▲ 217×1 topic
  7. Viral Vectors3▲ 217×1 topic
  8. Dendritic Cells3▲ 116×1 topic
  9. Tumor Antigen3▲ 165×1 topic
  10. Epidemiology3▲ 3.2×9 topics
  11. Immunotherapy2▲ 16×5 topics
  12. Tumor Microenvironment2▲ 24×2 topics
  13. Immune Checkpoint Blockade2▲ 140×1 topic
  14. PD-1 and PD-L12▲ 140×1 topic
  15. Vaccine2▲ 20×4 topics
  16. Glycosylation2▲ 35×3 topics
  17. Epitope Prediction1▲ 339×1 topic
  18. Immune Response1▲ 11×5 topics
  19. Peptide-MHC Binding1▲ 339×1 topic
  20. Tumor Regression1▲ 73×2 topics
  21. Herpes Zoster1▲ 104×1 topic
  22. Herpesviruses1▲ 104×1 topic

Which research topics does Nouscom (Italy) publish most on?

By volume in 2022–2025: Immunotherapy and Immune Responses, Virus-based gene therapy research, vaccines and immunoinformatics approaches and Cancer Immunotherapy and Biomarkers.

  1. 1 Immunotherapy and Immune Responses Immunology 2 works
  2. 2 Virus-based gene therapy research Genetics 1 works
  3. 3 vaccines and immunoinformatics approaches Molecular Biology 1 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
  5. 5 Genetic factors in colorectal cancer Pathology and Forensic Medicine 1 works
  6. 6 Cutaneous Melanoma Detection and Management Oncology 1 works
  7. 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  8. 8 Cancer Genomics and Diagnostics Cancer Research 0 works
  9. 9 CAR-T cell therapy research Oncology 0 works
  10. 10 Herpesvirus Infections and Treatments Epidemiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available81.6%not open18.4%

World: 28% of research is openly available.

with international co-authors34.7%domestic only65.3%

World: 19% is written across borders.

How has Nouscom (Italy)'s research output changed?

Output in 2018–2022 was 303% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Rome

All research institutions in Rome

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.